A critical discovery in cancer study is occurring with the use of mini-antibodies to restore mutated p53. This essential malignant inhibitor protein is frequently inactivated in several types of tumors, resulting https://sb-bookmarking.com/story22075043/mini-antibodies-revive-p53-the-potential-approach-for-malignant-therapy